Latest Stories
MTSI Q4 Deep Dive: Data Center, Defense, and Telecom Markets Fuel Growth and Guidance
Network chips maker MACOM Technology Solutions (NASDAQ: MTSI) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 24.5% year on year to $271.6 million. On top of that, next quarter’s revenue guidance ($285 million at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its non-GAAP profit of $1.02 per share was 2.2% above analysts’ consensus estimates.
XPO Q4 Deep Dive: Productivity Gains and Pricing Drive Outperformance in Freight Market
Freight delivery company XPO (NYSE:XPO) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 4.7% year on year to $2.01 billion. Its non-GAAP profit of $0.88 per share was 15.3% above analysts’ consensus estimates.
ARW Q4 Deep Dive: Value-Added Services and Gradual Demand Recovery Drive Results
Global electronics components and solutions distributor Arrow Electronics (NYSE:ARW) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.1% year on year to $8.75 billion. On top of that, next quarter’s revenue guidance ($8.25 billion at the midpoint) was surprisingly good and 9.3% above what analysts were expecting. Its non-GAAP profit of $4.39 per share was 23.1% above analysts’ consensus estimates.
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis
Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.
AGCO Q4 Deep Dive: Mixed Margins and Strategic Cost Actions Shape Outlook
Agricultural and farm machinery company AGCO (NYSE:AGCO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 1.1% year on year to $2.92 billion. The company’s full-year revenue guidance of $10.55 billion at the midpoint came in 5% above analysts’ estimates. Its GAAP profit of $1.29 per share was 25.9% below analysts’ consensus estimates.
WMS Q4 Deep Dive: Product Mix and Acquisitions Drive Margin Expansion
Water management company Advanced Drainage Systems (NYSE:WMS) announced better-than-expected revenue in Q4 CY2025, but sales were flat year on year at $693.4 million. The company’s full-year revenue guidance of $3.02 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $1.27 per share was 14.7% above analysts’ consensus estimates.
HII Q4 Deep Dive: Shipbuilding Throughput, Margin Stagnation, and Strategic Investments Shape Outlook
Aerospace and defense company Huntington Ingalls (NYSE:HII) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.7% year on year to $3.48 billion. Its non-GAAP profit of $4.04 per share was 5% above analysts’ consensus estimates.
THR Q4 Deep Dive: Data Center and Electrification Demand Drive Revenue Upside
Industrial process heating solutions provider Thermon (NYSE:THR) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.6% year on year to $147.3 million. The company’s full-year revenue guidance of $521 million at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $0.66 per share was 13.4% above analysts’ consensus estimates.
RAMP Q4 Deep Dive: AI Partnerships and Usage-Based Pricing Support Durable Growth
Data collaboration platform LiveRamp (NYSE:RAMP) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.6% year on year to $212.2 million. On the other hand, next quarter’s revenue guidance of $205 million was less impressive, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 12.8% above analysts’ consensus estimates.
BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 1.4% year on year to $12.5 billion. The company’s full-year revenue guidance of $46.75 billion at the midpoint came in 5.7% above analysts’ estimates. Its non-GAAP profit of $1.26 per share was 4.6% above analysts’ consensus estimates.